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Anti-carcinogenic activity of vitamin D comprises promotion 
of cell differentiation, induction of apoptosis, inhibition of 
cancer cell proliferation, regulation of expression of different 
proinflammatory cytokines and growth factors, as well anti 
angiogenic properties [2,3]. However, the evidence that vitamin 
D prevents development of colon cancer is inconsistent [3]. It 
is worth to underline that low serum vitamin D level might also 
result from many other malignancy risk factors such as: obesity 
(vitamin D sequestration in adipose tissue), lack of physical 
activity (less sunlight exposure), and difference in diet habits [3].
The deficiency of vitamin D has an important influence on 
the immune system function, and may interfere proper cellular 
immune response, especially of activated VDR-expressing 
monocytes, macrophages, dendritic cells, and lymphocytes 
[2,3]. Vitamin D promotes microbial killing in the macrophages 
and inhibits antigen-presenting capacity of the dendritic cells 
[3]. Acting through VDR in lymphocytes vitamin D inhibits their 
proliferation and differentiation to maturity, which results in 
suppression of the adaptive immune response [3]. 
Epidemiological studies show that prevalence of vitamin D 
insufficiency is common in patients with IBD - in children 55.6% 
of patients with Crohn’s disease (CD) and 63.6% of patients with 
ulcerative colitis (UC) have its sub-optimal (≤ 32ng/mL) serum 
level [4]. Low vitamin D level, (with insufficiency (20-30ng/mL) 
in 37% and deficiency (<20 ng/mL) in 23%) is found in 60% of 
adult IBD patients [5]. Especially exposed to low vitamin D levels 
are patients with pouchitis-69.4% [6]. 
The most important risk factors of vitamin D insufficiency 
comprise: mal absorption, resection of small intestine, decreased 
sunlight exposure, winter and spring season, higher body mass 
index Z-score, smoking and higher erythrocyte sedimentation 
rate [2,4].
In IBD patients hypovitaminosis D is associated with 
severer course of the disease, enhanced use of medications 
(corticosteroids, biologics, narcotics), increased risk of surgery 
and hospitalizations, and quality of life deterioration [7-9]. Low 
vitamin D level may also contribute to an increased risk of the 
CD onset [10]. Ananthakrishnan et al. [10] in a large prospective 
cohort study showed that each 100-IU/day increase in total 
vitamin D intake resulted in a 10% reduction in UC risk and a 7% 
reduction in CD risk [10]. 
Hypovitaminosis D, as well male gender, Asian ethnicity, and 
corticosteroids use are risk factors for low bone mineral density 
in IBD [5]. 
However, deficiency of vitamin D might be also connected 
with several nonskeletal effects, for instance an increased risk of 
Clostridium difficile infection [11]. Ananthakrishnan et al. [11] 
found that each 1ng/mL increase of vitamin D level in plasma 
was associated with a 4% reduction in risk of Clostridium difficile 
infection. 
Ananthakrishnan et al. [12] in a large IBD cohort (2809 
patients) study showed an increased risk of colon cancer in 
subjects with vitamin D deficiency (<20ng/mL). Each 1ng/
mL increase of vitamin D in plasma was associated with an 8% 
reduction in risk of colorectal cancer [12]. 
In view of all the above data, vitamin D supplementation might 
have an important impact on the course of IBD [1,13]. Jørgensen 
et al. [13] in a randomized double-blind placebo-controlled 
trialadministered vitamin D at the dose of 1200IU/d to CD patients 
and after three months they noticed reduced number of disease 
flares (13% vs. 29% in controls), however, the difference was not 
statistically significant [13]. Pappa HM et al. [4] in a pediatric group 
of patients with IBD after supplementation of vitamin D at the 
dose of 2000IU/d observed a lower level of C-reactive protein and 
interleukin-6. However, more interventional studies are required 
to confirm the therapeutic efficacy of vitamin D supplementation 
in IBD [14]. A target of vitamin D levels between 30 and 50 ng/mL 
appears to be both safe and have benefits for IBD disease course. 
Daily vitamin D doses between 1800-10,000IU/d are probably 
necessary [15].
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Introduction
The role of vitamin D in patients with inflammatory bowel 
diseases (IBD) has been for years underestimated [1]. This fat 
soluble vitamin is absorbed in jejunum and terminal ileum and 
directly and indirectly affects enterocytes leading to an increase 
in calcium absorption from the gastrointestinal tract [2]. The main 
role of vitamin D is regulation of calcium-phosphate homeostasis 
[2]. However, recently many studies indicate its pleiotropic effects, 
which is connected with the presence of vitamin D receptors 
(VDR) in different tissues [2,3].
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